MSSMaison Solutions Inc.

Nasdaq maisonsolutionsinc.com


$ 1.20 $ -0.04 (-3.31 %)    

Friday, 17-May-2024 15:59:57 EDT
QQQ $ 451.63 $ -0.22 (-0.05 %)
DIA $ 399.76 $ 0.74 (0.19 %)
SPY $ 529.24 $ 0.76 (0.14 %)
TLT $ 91.40 $ -0.62 (-0.67 %)
GLD $ 223.63 $ 3.63 (1.65 %)
$ 1.17
$ 1.20
$ 0.00 x 0
$ 0.00 x 0
$ 1.20 - $ 1.20
$ 0.68 - $ 22.97
20,825
na
22.74M
$ -3.27
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-18-2024 01-31-2024 10-Q
2 12-15-2023 10-31-2023 10-Q
3 09-12-2023 07-31-2023 10-Q
4 07-31-2023 04-30-2023 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 top-3-risk-off-stocks-that-are-set-to-fly-in-q1

The most oversold stocks in the consumer staples presents an opportunity to buy into undervalued companies.

 top-4-defensive-stocks-that-could-lead-to-your-biggest-gains-this-quarter

The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies.

 why-lantheus-holdings-shares-are-trading-lower-by-over-22-here-are-other-stocks-moving-in-mondays-mid-day-session

Shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) fell sharply during Monday’s session after the company and POINT Biopharma ann...

 on-friday-december-15-hindenburg-research-posted-on-x-we-believe-mss-is-slated-to-suffer-a-similar-fate-to-gdhg-and-that-retail-shareholders-will-once-again-be-left-holding-the-bag-on-a-massively-overvalued-company-we-are-short-mss

https://twitter.com/HindenburgRes/status/1735743118018765038Maison Solutions is a company that took 6 California Asian-themed g...

 maison-solutions-issues-statement-regarding-short-attack-on-its-securities

Maison Solutions Inc. ("Maison Solutions" or the "Company") (NASDAQ:MSS), a specialty grocery retailer offering...

 why-arcutis-biotherapeutics-shares-are-trading-higher-by-around-25-here-are-20-stocks-moving-premarket

Shares of Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) rose sharply in pre-market trading after the FDA approved company’s ZOR...

 maison-solutions-q2-eps-001-down-from-003-yoy-revenue-138m-down-from-142m-yoy

Fiscal 2024 Second Quarter Financial ResultsTotal revenues, net were $13.8 million for the fiscal 2024 second quarter, compared...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION